Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Severe Malaria Treatment With Rectal Artesunate and Artemisinin-based Combination Therapy in Remote Settings

NCT06806956 is registered in ClinicalTrials.gov with Tropical Diseases Research Centre, Zambia as lead sponsor.

NCT NCT06806956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06806956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Severe Malaria Treatment With Rectal Artesunate and Artemisinin-based Combination Therapy in Remote Settings
Lead sponsor
Tropical Diseases Research Centre, Zambia
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 10, 2024
Completion date
April 30, 2027
Enrollment
2,016 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

severe malaria